tiprankstipranks
Trending News
More News >
Quick Heal Technologies Ltd. (IN:QUICKHEAL)
:QUICKHEAL
India Market

Quick Heal Technologies Ltd. (QUICKHEAL) AI Stock Analysis

Compare
2 Followers

Top Page

IN:QUICKHEAL

Quick Heal Technologies Ltd.

(QUICKHEAL)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
,
Neutral 45 (OpenAI - 5.2)
,
Neutral 45 (OpenAI - 5.2)
,
Neutral 45 (OpenAI - 5.2)
,
Neutral 45 (OpenAI - 5.2)
,
Neutral 45 (OpenAI - 5.2)
,
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
₹147.00
▼(-45.31% Downside)
Action:ReiteratedDate:03/19/26
The score is pressured primarily by deteriorating financial performance (negative operating profitability and negative operating/free cash flow in FY2025) and bearish technicals (price below all major DMAs with negative MACD). A strong, low-debt balance sheet is the key stabilizer, but high valuation (P/E ~54.5) offers limited downside support.
Positive Factors
Conservative balance sheet / minimal leverage
A near-zero debt profile and sizable equity give the company durable financial flexibility, letting management fund R&D, support channel partners, or bridge cash burn without immediate refinancing. This stabilizes the business through cyclical weakness and supports strategic optionality.
High gross margins consistent with software model
Sustained high gross margins reflect scalable software economics and pricing power for endpoint products. Even if operating costs fluctuate, strong gross margins provide room for margin recovery as revenues stabilize, enabling long-term profitability improvements if operating leverage returns.
Recurring, channel-led licensing revenue model
A business built on license subscriptions, renewals and a broad channel network produces predictable recurring revenue and distribution scale. This structural model supports customer retention, recurring cash inflows and cost-effective go-to-market over multiple quarters to years.
Negative Factors
Declining revenue trend
A multi-year product or channel pressure is suggested by revenue decline, which reduces operating leverage and the ability to cover fixed costs. Persistent top-line contraction signals market share or demand challenges that can impair long-term margin recovery and strategic investment.
Deteriorated operating leverage / higher operating costs
Operating expenses rising relative to revenue has pushed EBIT/EBITDA margins negative. Weaker operating leverage means revenue swings disproportionately hit profits, making durable margin restoration dependent on either sustained revenue growth or structural cost reductions.
Negative operating and free cash flow
A reversal to negative OCF and FCF increases execution risk: management may need to draw reserves or limit investments. Over months this constrains R&D, channel support and sales programs, and reduces the buffer provided by the otherwise strong balance sheet if cash burn persists.

Quick Heal Technologies Ltd. (QUICKHEAL) vs. iShares MSCI India ETF (INDA)

Quick Heal Technologies Ltd. Business Overview & Revenue Model

Company DescriptionQuick Heal Technologies Limited provides security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. The company operates through Retail, Enterprise and Government, and Mobile segments. Its products portfolio includes GoDeep.AI, a malware hunting engine; Seqrite Hawk, a cybersecurity solution; and Hawk Eye, a cloud-based platform for enterprise grade centralized security management. The company also offers technical and after-sales support services. It sells its products through a network of service providers, system integrators, resellers, and distributors. The company offers its products under Seqrite brand. Quick Heal Technologies Limited was incorporated in 1995 and is based in Pune, India.
How the Company Makes MoneyQuick Heal Technologies makes money primarily by selling cybersecurity software licenses and subscriptions for its consumer and business products. Key revenue streams include: (1) Consumer security products (under the Quick Heal brand): revenue is generated from paid licenses (typically time-bound) sold via retail and digital channels, including first-time purchases and renewals/upgrades. (2) Enterprise/SMB cybersecurity solutions (under the Seqrite brand): revenue is generated from licensing endpoint and related security solutions to organizations, commonly on an annual or multi-year basis, with income from renewals as contracts continue. (3) Channel-led distribution: a significant portion of sales is typically executed through distributors, resellers, and retail partners who market and sell licenses to end customers; the company recognizes revenue from these product sales through its channel network. (4) Maintenance/renewals and allied services: ongoing renewals of expiring licenses and any associated support/maintenance components contribute to recurring revenue. Specific quantitative splits by stream, named partnerships, or exact pricing/contract structures are null.

Quick Heal Technologies Ltd. Financial Statement Overview

Summary
Balance sheet strength is a major positive (minimal leverage, sizable equity), but this is outweighed by weak recent operations: FY2025 revenue declined (~5.1% YoY), operating profitability turned negative (EBIT/EBITDA margins negative), net margin fell to ~1.8%, and operating/free cash flow were negative.
Income Statement
41
Neutral
Revenue has been largely flat to down recently, with FY2025 showing a ~5.1% decline versus FY2024. Profitability has weakened materially: FY2025 posted negative EBIT and EBITDA margins while net margin compressed to ~1.8% (down from ~8.3% in FY2024). The business still shows very high gross margin in FY2025, but the sharp deterioration at the operating line suggests elevated operating costs and weaker operating leverage, creating an uneven earnings profile versus the stronger profitability seen in earlier years (FY2020–FY2021).
Balance Sheet
86
Very Positive
The balance sheet is conservatively structured with minimal leverage (debt-to-equity near zero; FY2025 debt is negligible relative to equity). Equity remains sizable and assets are stable, which supports financial flexibility. The main drawback is softer returns on equity in the most recent year (FY2025 ROE ~1.1%), reflecting the weaker earnings base rather than balance-sheet strain.
Cash Flow
33
Negative
Cash generation has weakened meaningfully: FY2025 operating cash flow and free cash flow were both negative, a sharp reversal from positive cash generation in FY2024 and earlier years. This raises questions around working-capital/investment demands and the quality/consistency of earnings conversion. While cash flow was healthy historically (FY2020–FY2022), the latest year’s cash burn increases near-term execution risk until cash generation stabilizes.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.77B2.80B2.92B2.78B3.42B3.33B
Gross Profit2.72B2.72B1.17B1.14B1.92B2.04B
EBITDA78.90M-65.90M373.00M227.70M1.07B1.45B
Net Income-7.40M50.40M242.40M64.00M831.90M1.07B
Balance Sheet
Total Assets5.45B5.25B5.13B4.93B7.16B8.27B
Cash, Cash Equivalents and Short-Term Investments1.85B1.93B2.20B1.88B3.54B4.67B
Total Debt0.003.10M0.000.000.000.00
Total Liabilities988.80M835.60M756.30M735.90M882.50M752.10M
Stockholders Equity4.46B4.41B4.37B4.20B6.28B7.51B
Cash Flow
Free Cash Flow-189.90M-367.20M106.30M267.30M741.30M897.60M
Operating Cash Flow-54.30M-223.00M181.90M308.10M799.80M986.20M
Investing Cash Flow-102.90M159.70M61.50M1.85B1.26B-922.90M
Financing Cash Flow16.20M-103.20M16.00M-2.12B-2.14B1.00M

Quick Heal Technologies Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹15.85B21.870.42%21.17%27.66%
64
Neutral
₹17.72B1.71
62
Neutral
₹9.02B38.210.55%11.73%-64.05%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
54
Neutral
₹16.21B84.78155.87%
46
Neutral
₹4.58B56.55-9.53%96.99%
45
Neutral
₹7.84B54.491.08%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:QUICKHEAL
Quick Heal Technologies Ltd.
144.60
-168.05
-53.75%
IN:BCG
Brightcom Group Limited
8.78
-1.50
-14.59%
IN:IKIO
IKIO Lighting Limited
116.75
-176.35
-60.17%
IN:KERNEX
Kernex Microsystems India Ltd.
964.55
188.60
24.31%
IN:SAKSOFT
Saksoft Limited
119.55
-42.53
-26.24%
IN:SUBEXLTD
Subex Limited
8.15
-4.95
-37.79%

Quick Heal Technologies Ltd. Corporate Events

Quick Heal Board Clears Q3 FY26 Results, Senior Leadership Overhaul and Promoter Reclassification
Jan 29, 2026

Quick Heal Technologies Ltd. said its board has approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, along with the related limited review reports from its statutory auditors. The board also cleared several senior management changes, appointing Savita Nehra as Vice President – People and Culture, Amartya Mukherjee as Vice President and Head of Delivery, promoting Netra Deshpande to Head of Engineering, and appointing Nitin Bhogan as Director – Cyber Awareness, moves that signal a strengthening of leadership across key operational and technical functions. In addition, the board approved a request from Gagan Bharari Enterprises LLP to be reclassified from the Promoter and Promoter Group category to Public Shareholders, subject to stock exchange approvals, a shift that could modestly alter the company’s shareholding structure and float.

Quick Heal Board Clears Q3 FY26 Results, Strengthens Leadership and Backs Promoter Reclassification
Jan 29, 2026

Quick Heal Technologies Ltd. said its board, meeting via video conference on January 29, 2026, approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with the statutory auditors’ limited review reports, and released an accompanying press note and investor presentation. The board also strengthened its senior leadership bench with the appointment of new vice presidents for people and culture and for delivery, the promotion of a new head of engineering, and the appointment of a director for cyber awareness, while additionally backing the reclassification request of Gagan Bharari Enterprises LLP from ‘promoter and promoter group’ to ‘public shareholder’ status, subject to stock exchange approval, a move that could modestly alter the company’s shareholding structure and public float.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026